middl
east
respiratori
syndrom
coronaviru
merscov
first
identifi
saudi
arabia
sinc
laboratoryconfirm
case
merscov
identifi
result
death
case
fatal
rate
approxim
vast
major
merscov
case
occur
saudi
arabia
howev
travelassoci
case
identifi
addit
countri
remark
travelassoci
case
merscov
occur
south
korea
caus
outbreak
infect
individu
result
death
dromedari
camel
camelu
dromedariu
thought
zoonot
reservoir
merscov
transmit
viru
human
via
direct
contact
camel
camel
product
humantohuman
transmiss
appear
requir
close
contact
occur
within
household
nosocomi
transmiss
common
account
almost
mer
case
clinic
present
merscov
infect
rang
asymptomat
infect
mild
infect
present
sore
throat
fever
myalgia
sever
diseas
progress
pneumonia
acut
respiratori
distress
syndrom
multiorgan
failur
lead
death
limit
inform
pathogenesi
merscov
human
autopsi
publish
studi
show
similar
lung
patholog
diffus
alveolar
damag
promin
patholog
featur
along
hyalin
membran
format
edema
mix
inflammatori
infiltr
although
littl
known
mechan
pathogenesi
merscov
human
sever
epidemiolog
studi
look
varieti
aspect
merscov
infect
includ
transmiss
indic
clinic
outcom
risk
factor
contribut
develop
sever
lethal
diseas
risk
factor
associ
develop
sever
diseas
death
follow
merscov
infect
includ
male
sex
older
age
comorbid
ill
particular
diabet
kidney
diseas
heart
diseas
underli
respiratori
diseas
hypertens
shown
predispos
patient
sever
lethal
diseas
merscov
infect
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
saudi
arabia
caus
case
death
epidemiolog
studi
identifi
diabet
primari
comorbid
associ
sever
lethal
merscov
infect
understand
diabet
affect
mer
import
global
burden
diabet
pandem
potenti
merscov
use
model
mice
made
suscept
merscov
express
human
type
diabet
induc
administ
highfat
diet
upon
infect
merscov
diabet
mice
prolong
phase
sever
diseas
delay
recoveri
independ
viru
titer
histolog
analysi
reveal
diabet
mice
delay
inflamm
prolong
day
infect
diabet
mice
fewer
inflammatori
monocytemacrophag
cell
correl
lower
level
express
diabet
mice
also
lower
level
tnfa
express
higher
level
express
data
suggest
increas
diseas
sever
observ
individu
mer
comorbid
type
diabet
like
due
dysregul
immun
respons
result
sever
prolong
lung
patholog
comorbid
ill
increas
risk
sever
diseas
furthermor
asymptomat
individu
less
like
underli
comorbid
compar
fatal
case
transmiss
studi
within
singl
extend
famili
member
test
posit
merscov
time
like
comorbid
diseas
one
studi
found
individu
diabet
poor
diseas
outcom
character
intens
care
unit
admiss
death
compar
individu
type
nondiabet
comorbid
suggest
diabet
particular
major
contributor
merscov
diseas
sever
although
larg
amount
heterogen
level
risk
associ
variou
comorbid
studi
design
target
popul
report
demonstr
diabet
signific
risk
factor
develop
sever
lethal
diseas
merscov
infect
odd
ratio
develop
sever
lethal
diseas
follow
merscov
infect
one
comorbid
diabet
rang
depend
studi
design
popul
interestingli
diabet
also
shown
risk
factor
lower
respiratori
tract
infect
includ
mycobacterium
tuberculosi
tuberculosi
burkholderia
pseudomallei
b
pseudomallei
influenza
viru
million
peopl
across
globe
diabet
classifi
type
diabet
type
diabet
result
hyperglycemia
mechan
occur
differ
typic
result
autoimmunelik
diseas
cell
pancrea
destroy
result
decreas
insulin
product
howev
result
bodi
inabl
respond
properli
insulin
preval
form
diabet
constitut
diabet
case
etiolog
close
intertwin
obes
result
chronic
inflamm
induc
excess
adipos
tissu
stress
adipocyt
adipos
tissu
macrophag
secret
numer
proinflammatori
mediat
result
chronic
lowgrad
inflamm
alter
homeostat
glucos
regul
decreas
cellular
respons
insulin
result
key
physiolog
characterist
hyperglycemia
hyperinsulinemia
glucos
intoler
human
mice
exhibit
switch
predomin
regulatori
antiinflammatori
macrophag
regulatori
cell
treg
adipos
tissu
predomin
proinflammatori
macrophag
cell
alter
immun
profil
thought
contribut
varieti
consequ
associ
includ
increas
suscept
infect
recent
small
anim
model
suitabl
studi
merscov
infect
creat
mechan
pathogenesi
abl
studi
merscov
replic
wildtyp
mice
differ
receptor
bind
domain
overcom
mani
group
includ
develop
transgen
mice
express
human
model
exon
mous
replac
human
sequenc
hm
mice
express
human
appropri
cell
type
includ
noncili
epitheli
cell
alveolar
type
cell
support
merscov
replic
lung
follow
infect
merscov
jordan
mice
lose
weight
show
clinic
sign
ill
includ
labor
breath
lethargi
exhibit
pulmonari
histopatholog
characterist
similar
observ
human
furthermor
observ
immun
cell
infiltr
primarili
character
monocytemacrophag
cell
well
increas
express
proinflammatori
cytokin
chemokin
immun
cell
deplet
studi
shown
cell
may
play
role
promot
tissu
damag
wherea
macrophag
may
play
role
protect
human
mous
model
studi
merscov
pathogenesi
also
shown
critic
role
inflammatori
macrophag
monocyt
imm
well
cell
coordin
appropri
immun
respons
follow
merscov
infect
understand
diabet
contribut
diseas
sever
follow
merscov
infect
treat
infect
context
critic
ongo
transmiss
merscov
continu
saudi
arabia
countri
also
high
preval
approxim
addit
merscov
highconsequ
respiratori
pathogen
pandem
potenti
along
global
burden
diabet
highlight
need
understand
role
diabet
merscov
pathogenesi
success
develop
small
anim
model
suscept
merscov
infect
develop
mimic
human
condit
studi
effect
comorbid
diabet
merscov
pathogenesi
male
hm
mice
fed
highfat
diet
hfd
week
develop
hyperglycemia
hyperinsulinemia
glucos
intoler
characterist
human
follow
infect
merscov
diabet
hm
mice
exhibit
sever
diseas
character
prolong
period
weight
loss
clinic
diseas
exacerb
prolong
diseas
diabet
hm
mice
appear
due
increas
viru
replic
slower
viru
clearanc
lung
howev
diabet
mice
exhibit
dysregul
immun
respons
infect
histolog
flow
cytometr
analysi
lung
reveal
diabet
mice
delay
initi
inflamm
lung
exemplifi
reduc
cell
imm
recruit
slower
resolv
lung
inflamm
compar
control
mice
addit
observ
delay
dampen
chemokin
express
diabet
mice
along
alter
cytokin
profil
model
demonstr
comorbid
diabet
hfd
model
result
dysregul
immun
respons
merscov
infect
help
elucid
mechan
pathogenesi
may
occur
human
diabet
provid
model
studi
therapeut
highli
suscept
popul
diabet
signific
risk
factor
develop
sever
lethal
diseas
follow
merscov
infect
human
sought
determin
diabet
predispos
human
increas
morbid
mortal
merscov
infect
creat
small
anim
model
permiss
merscov
infect
previous
character
mous
model
show
signific
patholog
follow
merscov
infect
exon
mous
replac
human
sequenc
hh
mice
background
importantli
mice
suscept
develop
obes
fed
hfd
extend
period
although
observ
physiolog
immunolog
differ
hh
wildtyp
mice
chose
use
mice
heterozygot
human
allel
hm
avoid
unknown
speciesspecif
complic
induc
male
femal
mice
fed
either
normal
diet
hfd
begin
week
age
maintain
specifi
diet
week
mice
evalu
develop
metabol
diseas
studi
focus
anim
model
obes
diabet
found
sexspecif
differ
mice
male
suscept
obes
reason
experiment
group
stratifi
diet
sex
male
femal
mice
maintain
hfd
week
weigh
significantli
control
counterpart
figur
p
male
fed
hfd
gain
significantli
weight
hfd
femal
figur
p
determin
whether
hfd
hm
mice
develop
characterist
perform
metabol
test
evalu
hyperglycemia
hyperinsulinemia
glucos
toler
hyperglycemia
determin
fast
mice
hour
blood
glucos
level
determin
hfd
male
femal
hm
mice
significantli
higher
concentr
glucos
blood
compar
control
mice
figur
p
hfd
male
mice
significantli
higher
level
glucos
blood
compar
hfd
femal
figur
p
fast
serum
insulin
level
determin
elisa
evalu
develop
hyperinsulinemia
hfd
hm
mice
hfd
male
mice
significantli
higher
level
serum
insulin
compar
control
male
wherea
hfd
femal
similar
level
serum
insulin
control
mice
figur
p
final
evalu
glucos
toler
hfd
hm
mice
use
intraperiton
glucos
toler
test
ipgtt
measur
quickli
bolu
glucos
control
healthi
mous
control
blood
glucos
level
within
hour
glucos
administr
wherea
glucos
level
remain
elev
mice
glucos
intoler
reduc
insulin
function
expect
control
male
femal
mice
exhibit
glucos
toler
blood
glucos
level
peak
minut
administr
reduc
baselin
level
hour
administr
howev
hfd
male
figur
p
femal
mice
figur
p
exhibit
signific
glucos
intoler
glucos
toler
also
assess
determin
area
curv
auc
ipgtt
measur
time
cours
auc
ipgtt
hfd
male
femal
hm
mice
significantli
greater
control
mice
figur
p
male
hfd
mice
greater
auc
ipgtt
femal
hfd
mice
figur
p
togeth
data
show
male
hm
mice
fed
hfd
develop
metabol
diseas
consist
human
character
hyperglycemia
hyperinsulinemia
glucos
intoler
wherea
femal
hm
mice
fed
hfd
develop
less
sever
metabol
diseas
character
mild
hyperglycemia
glucos
intoler
hyperinsulinemia
continu
use
hfd
male
hm
diabet
mice
hfd
femal
hm
hfd
mice
remaind
studi
determin
whether
extent
affect
merscov
pathogenesi
remaind
paper
hfd
male
mice
refer
diabet
hfd
femal
mice
refer
hfd
develop
mild
metabol
syndrom
associ
obes
meet
criteria
next
want
determin
whether
diabet
affect
clinic
cours
diseas
diabet
male
hfd
femal
mice
along
control
male
femal
mice
intranas
infect
pfu
merscov
jordan
evalu
daili
weight
loss
appear
clinic
sign
diseas
male
diabet
mice
lost
similar
percentag
initi
bodi
weight
control
mice
infect
howev
diabet
mice
slower
add
weight
figur
p
weight
differ
diabet
control
mice
also
look
chang
absolut
mass
lost
found
diabet
mice
continu
lose
weight
longer
period
control
mice
lost
significantli
net
mass
follow
merscov
infect
figur
p
diabet
male
mice
also
exhibit
prolong
sever
clinic
sign
diseas
persist
day
infect
labor
breath
notabl
featur
persist
diabet
male
mice
figur
p
clinic
cours
diseas
similar
femal
hfd
control
mice
less
differ
extent
weight
lost
figur
b
howev
elev
clinic
score
observ
day
infect
hfd
femal
mice
compar
normal
femal
mice
figur
lethal
diseas
model
defin
either
found
dead
cage
reach
weight
loss
observ
signific
differ
mortal
diabet
control
male
mice
hfd
control
femal
mice
supplement
tabl
supplement
materi
avail
onlin
articl
http
data
demonstr
util
anim
studi
diabet
affect
merscov
pathogenesi
data
show
diabet
hm
mice
prolong
sever
diseas
follow
merscov
infect
character
extend
period
weight
loss
persist
labor
breath
day
infect
date
studi
perform
human
analyz
viru
titer
context
comorbid
diabet
previous
shown
mous
model
higher
level
viru
replic
associ
sever
merscov
infect
determin
whether
viru
replic
alter
diabet
mice
infect
diabet
control
male
hfd
control
femal
mice
pfu
merscov
jordan
euthan
mice
day
analysi
lung
tissu
homogen
pb
infecti
viru
titer
determin
plaqu
assay
observ
differ
viru
titer
diabet
control
male
figur
hfd
control
femal
mice
figur
also
quantifi
amount
merscov
genom
rna
mrna
lung
diabet
control
mice
infect
found
differ
amount
genom
viru
rna
viru
mrna
lung
diabet
control
male
togeth
data
suggest
viru
replic
clearanc
affect
diabet
hfd
clear
common
extrapulmonari
dissemin
replic
merscov
human
minim
amount
virolog
data
patient
mer
one
human
autopsi
case
studi
cite
presenc
viru
antigen
lung
well
spleen
wherea
avail
autopsi
find
evid
extrapulmonari
viru
neither
individu
report
diabet
furthermor
anoth
studi
found
viru
blood
urin
individu
diabet
clinic
score
determin
follow
scale
healthi
slight
ruffl
fur
alter
hind
limb
postur
mildli
labor
breath
lethargi
moder
labor
breath
lethargi
sever
labor
breath
sever
lethargi
dead
data
present
mean
sem
pool
independ
experi
n
micegroup
p
p
p
p
determin
anova
posttest
succumb
infect
wherea
individu
diabet
surviv
posit
respiratori
sampl
determin
whether
diabet
lead
extrapulmonari
viru
dissemin
infect
mice
pfu
merscov
jordan
collect
lung
brain
kidney
liver
spleen
whole
blood
diabet
control
male
hfd
control
femal
mice
day
infect
rna
isol
tissu
level
genom
viru
rna
viru
mrna
determin
quantit
revers
transcript
pcr
qrtpcr
found
differ
amount
genom
viru
rna
viru
mrna
lung
diabet
control
male
mice
figur
g
howev
hfd
femal
mice
lower
level
viru
genom
rna
mrna
compar
control
mice
day
infect
figur
h
j
merscov
genom
rna
detect
blood
lesser
degre
liver
spleen
diabet
control
mice
well
hfd
control
femal
mice
howev
level
detect
much
lower
observ
lung
figur
gj
merscov
mrna
marker
activ
viru
replic
detect
lung
lesser
degre
blood
mice
figur
j
differ
amount
genom
viru
rna
viru
mrna
observ
extrapulmonari
tissu
blood
isol
diabet
male
control
mice
hfd
control
femal
mice
figur
gj
data
suggest
prolong
diseas
follow
merscov
infect
due
increas
viru
replic
delay
viru
clearanc
increas
extrapulmonari
dissemin
viru
rna
isol
level
viral
genom
rna
b
e
viral
mrna
c
f
determin
use
qrtpcr
target
upe
respect
data
normal
transferrin
receptor
protein
tfrc
normal
pb
control
present
rel
unit
data
pool
independ
experi
n
micegroup
present
mean
sem
gj
lung
whole
blood
brain
liver
kidney
spleen
infect
male
g
femal
h
j
mice
day
infect
viru
genom
rna
g
h
viru
mrna
j
determin
use
qrtpcr
target
upe
respect
data
normal
tfrc
normal
pb
control
present
rel
unit
data
n
micegroup
present
mean
sem
weight
loss
appear
clinic
sign
diseas
typic
associ
lung
patholog
better
understand
kinet
lung
inflamm
patholog
follow
merscov
infect
diabet
mice
infect
mice
pfu
merscov
jordan
collect
lung
tissu
day
infect
lung
tissu
stain
hematoxylin
eosin
histolog
examin
slide
blind
score
boardcertifi
pathologist
inflamm
lung
patholog
tabl
control
male
figur
femal
supplement
figur
mice
moder
degre
lung
inflamm
day
infect
predomin
locat
around
vasculatur
limit
bronchiolar
inflamm
contrast
male
diabet
mice
figur
femal
hfd
mice
supplement
figur
significantli
less
perivascular
inflamm
compar
control
mice
day
infect
around
day
merscov
infect
lung
patholog
similar
diabet
control
male
mice
hfd
control
femal
mice
character
increas
bronchiolar
perivascular
inflamm
compos
primarili
mix
macrophag
averag
score
n
micegroup
inflamm
scant
inflamm
mild
inflamm
parenchyma
moder
inflamm
parenchyma
mark
inflamm
parenchyma
sever
infalmm
parenchyma
ctrl
control
db
diabet
dpi
day
infect
eosinophil
neutrophil
macrophag
lymphocyt
interstitialalveolar
necrosi
bronchiolar
necrosi
averag
score
n
micegroup
lymphocyt
infiltr
appar
granulocyt
day
infect
diabet
male
mice
still
exhibit
signific
lung
patholog
inflamm
compar
control
male
mice
figur
bd
wherea
inflamm
femal
hfd
mice
similar
observ
control
mice
supplement
figur
bd
edema
evid
day
follow
infect
increas
day
infect
resolv
day
infect
differ
observ
diabet
control
male
mice
hfd
control
femal
mice
tabl
minim
amount
hemorrhag
alveolar
bronchiolar
interstiti
necrosi
observ
diabet
control
male
mice
hfd
control
femal
mice
infect
tabl
data
suggest
delay
immun
respons
diabet
mice
along
inabl
resolv
inflamm
lung
patholog
contribut
sever
diseas
follow
merscov
infect
diabet
mice
decreas
cell
inflammatori
monocytemacrophag
respons
follow
merscov
infect
patholog
data
demonstr
kinet
degre
inflamm
lung
diabet
male
mice
alter
compar
control
mice
better
defin
immun
respons
merscov
infect
context
diabet
want
determin
kinet
immun
cell
infiltr
lung
diabet
male
hfd
femal
control
merscovinfect
mice
singl
cell
isol
lung
tissu
uninfect
merscovinfect
mice
day
infect
flow
cytometr
analysi
perform
identifi
immun
cell
cell
cell
cell
b
cell
nk
cell
neutrophil
imm
gate
scheme
supplement
figur
summari
number
frequenc
immun
cell
subset
found
supplement
tabl
found
cell
lung
control
male
mice
cell
compar
diabet
male
mice
cell
day
infect
figur
similar
number
cell
figur
higher
infect
figur
frequenc
b
cell
significantli
lower
day
infect
infect
supplement
tabl
diabet
male
mice
fewer
cell
day
infect
compar
control
male
mice
although
data
reach
statist
signific
account
multipl
comparison
dpi
vs
cell
dpi
vs
cell
figur
howev
frequenc
cell
lower
day
infect
supplement
tabl
also
found
male
diabet
mice
significantli
fewer
imm
lung
day
infect
compar
control
male
mice
vs
cell
p
figur
femal
hfd
mice
significantli
fewer
neutrophil
day
infect
supplement
figur
differ
total
number
cell
immun
cell
subset
infect
supplement
figur
data
suggest
immun
respons
merscov
infect
dysregul
diabet
mice
fewer
imm
cell
recruit
lung
cytokin
chemokin
gene
express
alter
male
diabet
hm
mice
merscov
infect
immun
cell
infiltr
coordin
shape
induct
chemokin
cytokin
infect
neighbor
cell
found
cellular
infiltr
alter
diabet
male
mice
hfd
femal
mice
merscov
infect
hypothes
may
alter
chemokin
respons
cellular
recruit
diabet
male
mice
investig
perform
gene
express
analysi
use
qrtpcr
rna
isol
lung
male
diabet
control
mice
well
femal
hfd
control
mice
infect
merscov
day
infect
first
focus
drive
monocyt
lymphocyt
recruit
respect
previous
shown
upregul
merscov
infect
mous
model
found
diabet
male
mice
significantli
reduc
level
express
day
p
p
infect
figur
also
found
diabet
male
mice
significantli
lower
level
express
day
infect
p
express
similar
femal
hfd
control
mice
figur
express
actual
higher
hfd
femal
mice
day
infect
p
figur
significantli
less
chemokin
express
earli
infect
may
play
role
delay
recruit
immun
cell
site
infect
male
diabet
mice
next
look
cytokin
cell
produc
flow
cytometri
data
demonstr
reduct
cell
determin
whether
also
chang
cytokin
indic
cell
function
focus
ifng
transcript
factor
evalu
treg
skew
respect
found
littl
express
merscov
male
figur
femal
supplement
figur
mice
regardless
metabol
statu
ifng
express
peak
day
infect
similar
male
diabet
control
mice
figur
significantli
lower
femal
hfd
mice
supplement
figur
p
interestingli
observ
significantli
higher
express
male
diabet
mice
begin
day
infect
p
elev
express
compar
control
mice
continu
day
infect
figur
wherea
femal
mice
littl
upregul
follow
merscov
infect
supplement
figur
also
found
express
higher
day
infect
diabet
male
figur
p
hfd
femal
supplement
figur
p
mice
data
suggest
fewer
cell
lung
diabet
mice
may
also
differ
skew
cell
promin
respons
diabet
male
mice
may
contribut
diseas
sever
along
promin
treg
respons
day
infect
inflamm
control
mice
diminish
previou
work
show
macrophag
play
import
role
merscov
pathogenesi
furthermor
macrophag
skew
shown
import
sarscov
pathogenesi
evalu
effect
diabet
macrophag
skew
merscov
infect
evalu
gene
express
pattern
proinflammatori
gene
tnfa
well
antiinflammatori
gene
diabet
male
mice
reduc
upregul
tnfa
p
p
day
infect
figur
reduc
upregul
day
infect
figur
howev
express
upregul
similarli
lung
male
diabet
control
mice
merscov
infect
figur
express
similar
male
diabet
control
mice
figur
express
reduc
upregul
p
p
day
infect
male
diabet
mice
figur
differ
tnfa
found
femal
hfd
control
mice
supplement
figur
data
suggest
diabet
mice
reduc
chemokin
express
result
delay
immun
cell
recruit
lung
merscov
infect
furthermor
cell
macrophag
respons
lower
diabet
mice
cytokin
profil
associ
cell
subset
also
alter
immun
dysregul
observ
may
contribut
sever
pathogenesi
merscov
diabet
mice
clinic
epidemiolog
analys
identifi
preexist
comorbid
includ
diabet
import
risk
factor
develop
sever
lethal
diseas
follow
merscov
infect
understand
diabet
contribut
merscov
pathogenesi
develop
small
anim
model
suscept
merscov
infect
induc
hfd
figur
follow
infect
merscov
diabet
hm
mice
exhibit
sever
clinic
symptom
character
prolong
period
weight
loss
clinic
diseas
lung
histolog
reveal
delay
initi
inflamm
slower
inflammatori
resolut
figur
flow
cytometr
analysi
show
imm
respons
lesser
extent
cell
respons
alter
diabet
mice
follow
merscov
infect
delay
infiltr
kinet
fewer
cell
peak
inflamm
reduc
chemokin
cytokin
induct
figur
merscov
infect
wildtyp
mice
differ
receptor
bind
domain
cellular
receptor
reason
need
use
mice
transgen
human
product
infect
aminopeptidas
exist
form
membran
bound
secret
play
role
variou
physiolog
process
includ
immun
respons
glucos
metabol
act
costimulatori
molecul
cell
interact
variou
protein
includ
adenosin
deaminas
enzymat
activ
result
cleavag
varieti
protein
target
includ
cytokin
chemokin
growth
factor
alter
function
enzymat
activ
also
target
incretin
glucagonlik
gastric
inhibitori
peptid
cleav
molecul
lead
decreas
insulin
secret
antidiabet
drug
known
gliptin
target
enzymat
activ
block
cleavag
thu
increas
insulin
secret
decreas
blood
glucos
level
gliptin
also
found
alter
immun
respons
mice
human
note
ic
wide
rang
gliptin
similar
mice
human
enzymat
inhibit
test
vitro
found
hm
mice
develop
similarli
wildtyp
mice
fed
hfd
speci
crossreact
gliptin
well
drug
use
treat
includ
metformin
sulfonylurea
allow
us
studi
effect
drug
merscov
pathogenesi
although
found
differ
wildtyp
human
mice
regard
immun
respons
glucos
metabol
rule
hm
mice
alter
compar
wildtyp
mice
obes
diabet
identifi
signific
risk
factor
sever
diseas
follow
lower
respiratori
tract
infect
diabet
particular
associ
wors
diseas
follow
merscov
tuberculosi
b
pseudomallei
infect
wherea
obes
often
associ
wors
diseas
follow
influenza
infect
diabet
obes
result
dysregul
immun
respons
respiratori
infect
delin
effect
excess
adipos
tissu
dyslipidemia
associ
obes
compar
effect
hyperglycemia
excess
insulin
product
associ
immun
respons
infect
evalu
part
reason
obes
close
link
etiolog
thought
due
chronic
inflamm
induc
excess
adipos
tissu
obes
etiolog
hfd
mous
model
use
studi
obes
well
genet
model
obes
mice
lack
leptin
gene
obob
leptin
receptor
dbdb
also
result
metabol
syndrom
make
difficult
delin
contribut
obes
alon
futur
studi
includ
creat
lean
hyperglycem
mous
model
recapitul
metabol
syndrom
associ
suscept
merscov
infect
determin
contribut
hyperglycemia
absenc
obes
lean
hyperglycem
model
also
use
studi
effect
hyperglycemia
alon
respiratori
infect
includ
influenza
viru
bacteri
pathogen
sexspecif
differ
develop
obes
metabol
diseas
also
exist
human
mice
male
mice
suscept
femal
dietinduc
obes
subsequ
develop
metabol
diseas
similarli
found
hfd
hm
male
mice
exhibit
sever
diabet
compar
hfd
femal
mice
figur
sever
factor
thought
contribut
sexual
dimorph
develop
obesityrel
metabol
diseas
includ
sexspecif
differ
immun
cell
develop
function
adiposerel
immun
activ
adipocyt
prolifer
develop
contribut
sex
steroid
adipocyt
reason
major
studi
investig
effect
obes
pathogenesi
infecti
diseas
use
male
mice
chose
compar
hfdinduc
diabet
male
hfd
femal
mice
better
understand
sever
diabet
affect
pathogenesi
found
diabet
male
mice
experienc
sever
diseas
follow
merscov
character
promin
delay
cellular
infiltr
prolong
lung
patholog
alter
cell
imm
pulmonari
infiltr
dysregul
cytokin
chemokin
respons
although
hfd
femal
hm
mice
develop
mild
metabol
syndrom
littl
effect
clinic
cours
diseas
lung
patholog
minor
delay
cellular
infiltr
minim
effect
cytokin
chemokin
express
immun
cell
infiltr
lung
data
demonstr
sever
diabet
poor
glycem
control
lead
sever
merscovinduc
diseas
suggest
patient
diabet
effect
treat
diabet
may
high
risk
sever
mer
diseas
uncontrol
glucos
level
increas
infect
viral
bacteri
pathogen
character
diabet
human
anim
model
infect
tuberculosi
b
pseudomallei
previous
shown
lead
reduc
abil
control
bacteri
replic
lead
system
dissemin
diabet
observ
differ
merscov
replic
clearanc
lung
diabet
mice
furthermor
observ
differ
level
genom
viral
rna
viral
mrna
extrapulmonari
tissu
diabet
hfd
mice
data
suggest
increas
system
spread
merscov
caus
increas
diseas
sever
observ
bacteri
respiratori
pathogen
immun
dysfunct
context
diabet
alon
follow
infect
report
wide
varieti
immun
cell
monocyt
macrophag
cell
although
differ
recruit
lung
follow
merscov
infect
note
neutrophil
nk
cell
cell
determin
function
cell
along
character
dc
nk
cell
cell
respons
import
further
understand
diabet
affect
merscov
pathogenesi
cell
particular
interest
previous
shown
cell
play
deleteri
role
merscov
infect
human
mous
model
human
antigenspecif
cell
found
patient
acut
merscov
infect
correl
diseas
sever
although
number
cell
found
lung
respons
merscov
infect
alter
diabet
mice
cytotox
function
cell
may
diabet
human
infect
tuberculosi
cell
number
circul
similar
healthi
patient
higher
frequenc
cell
produc
ifn
along
decreas
antigenspecif
express
cytotox
marker
cell
contribut
merscov
pathogenesi
clear
found
alter
cell
respons
merscov
infect
diabet
mice
although
lesser
extent
found
differ
imm
respons
magnitud
infiltr
cell
reduc
first
day
follow
merscov
infect
diabet
mice
correl
lower
level
express
lung
addit
dampen
cellular
recruit
decreas
cell
could
also
due
reduct
prolif
capac
cell
observ
previous
hyperglycem
condit
analysi
human
sera
patient
mer
show
serum
cytokin
profil
indic
respons
similarli
saw
upregul
ifng
lung
merscovinfect
mice
diabet
mice
higher
upregul
suggest
addit
decreas
number
cell
lung
diabet
mice
function
profil
cell
compart
may
alter
effect
increas
increas
cell
respons
merscov
infect
known
howev
respiratori
viral
infect
influenza
increas
respons
pathogen
protect
depend
context
diabet
result
proinflammatori
homeostat
immun
respons
skew
toward
cell
decreas
treg
similarli
diabet
human
infect
tuberculosi
increas
antigenspecif
cell
nonantigenspecif
antigenspecif
cell
well
increas
serum
level
cytokin
observ
increas
express
diabet
mice
may
also
come
cellular
sourc
includ
cell
cell
nk
cell
innat
lymphoidlik
type
cell
neutrophil
interestingli
higher
level
express
observ
day
infect
diabet
mice
follow
merscov
infect
suggest
immunoregulatori
cell
respons
follow
merscov
infect
affect
diabet
futur
studi
focus
determin
function
differ
cell
import
diabet
mice
follow
merscov
infect
macrophag
infiltr
found
lung
merscovinfect
patient
previous
shown
macrophag
protect
merscov
infect
anim
model
howev
differ
anim
model
merscov
requir
mouseadapt
merscov
strain
increas
imm
respons
decreas
nk
b
cell
respons
virul
infect
suggest
pathogen
role
cell
found
diabet
mice
fewer
imm
lung
day
merscov
infect
correl
lower
level
express
macrophag
skew
affect
lung
resolv
infect
tissu
damag
diabet
macrophag
function
alter
switch
predomin
macrophag
homeostasi
proinflammatori
macrophag
found
reduc
express
macrophageassoci
cytokin
tnfa
lung
diabet
mice
infect
merscov
respons
similar
observ
bacteri
infect
macrophag
diabet
mice
human
shown
reduc
phagocyt
function
express
proinflammatori
gene
express
begin
declin
around
day
merscov
infect
control
mice
upregul
marker
suggest
switch
regulatori
macrophag
phenotyp
import
resolv
inflamm
promot
wound
heal
diabet
mice
upregul
effici
control
mice
suggest
defect
initi
regulatori
respons
improp
initi
regulatori
macrophag
respons
may
contribut
prolong
lung
patholog
inflamm
observ
diabet
mice
although
infiltr
imm
analyz
studi
delin
effect
diabet
function
infiltr
imm
well
resid
alveolar
macrophag
cell
subset
affect
diseas
outcom
import
better
understand
diabet
lead
wors
diseas
follow
merscov
infect
develop
small
anim
model
recapitul
human
epidemiolog
observ
patient
comorbid
diabet
sever
diseas
merscov
infect
shown
sever
prolong
diseas
associ
dysregul
immun
respons
upon
infect
mani
immun
characterist
observ
diabet
mice
follow
merscov
infect
also
identifi
diabet
follow
respiratori
bacteri
infect
suggest
may
common
mechan
dysfunct
respiratori
tract
diabet
broader
implic
therapeut
develop
human
mer
patient
comorbid
diabet
also
show
evid
increas
lethal
current
model
recapitul
featur
futur
studi
perform
increas
lethal
increas
dose
viru
use
use
mouseadapt
merscov
strain
previous
develop
current
model
studi
diabet
merscov
infect
provid
opportun
investig
wide
varieti
question
contribut
age
diseas
sever
diabet
mice
drug
affect
pathogenesi
diseas
outcom
efficaci
current
therapeut
vaccin
context
diabet
model
steppingston
understand
diabet
affect
merscov
pathogenesi
effect
develop
therapeut
vaccin
highne
popul
viru
cell
merscov
jordan
strain
genbank
access
use
studi
merscov
jordan
propag
vero
cell
maintain
minimum
essenti
medium
corn
supplement
vv
fetal
bovin
serum
fb
milliporesigma
vv
lglutamin
gibco
thermo
fisher
scientif
vv
penicillinstreptomycin
gemini
bioproduct
co
medium
collect
day
infect
centrifug
remov
cellular
debri
result
inoculum
titer
use
plaqu
assay
vero
cell
experi
live
merscov
perform
biosafeti
level
condit
univers
maryland
school
medicin
induct
diabet
mice
mice
describ
previous
use
experi
hm
mice
bred
maintain
univers
maryland
school
medicin
cross
hh
mice
wildtyp
mice
mm
week
age
mice
put
diet
normal
chow
kcal
fat
teklad
diet
consist
highfat
chow
kcal
fat
teklad
maintain
diet
week
week
mice
weigh
test
elev
blood
glucos
level
glucos
intoler
evalu
glucos
intoler
use
ipgtt
normalchow
highfatchow
mice
fast
overnight
hour
weigh
baselin
fast
glucos
level
measur
use
contour
glucos
test
strip
glucos
meter
bayer
wv
solut
glucos
prepar
fresh
pb
administ
via
intraperiton
inject
final
concentr
gkg
blood
glucos
level
monitor
minut
glucos
administr
result
valu
normal
baselin
glucos
level
auc
determin
insulin
elisa
mice
fast
hour
blood
collect
via
retroorbit
bleed
serum
isol
determin
serum
insulin
concentr
use
insulin
elisa
kit
crystal
chem
perform
assay
accord
manufactur
protocol
mous
infect
experi
use
male
femal
hm
mice
maintain
either
normal
chow
highfat
chow
week
week
age
mice
infect
approxim
week
follow
diabet
test
allow
adequ
time
recov
fast
ipgtt
infect
mice
transfer
anim
biosafeti
level
facil
univers
maryland
school
medicin
allow
acclim
least
day
mice
anesthet
intraperiton
inject
use
mix
xylazin
ketamin
dilut
pb
anesthet
mice
intranas
inocul
pb
pfu
pfu
merscov
jordan
dilut
pb
total
inocul
volum
mice
weigh
monitor
daili
clinic
score
mice
score
use
follow
scale
healthi
slight
ruffl
fur
alter
hind
limb
postur
mildli
labor
breath
lethargi
moder
labor
breath
lethargi
sever
labor
breath
sever
lethargi
dead
mice
lost
start
bodi
weight
euthan
use
isofluran
butler
anim
health
suppli
mice
found
dead
cage
score
mice
euthan
reach
weight
loss
criterion
score
last
observ
tissu
collect
perform
infect
mice
day
infect
mice
euthan
use
isofluran
lung
collect
homogen
trizol
rna
extract
pb
viru
quantif
store
lung
section
fix
store
neutral
buffer
formalin
histolog
evalu
merscov
quantif
determin
infecti
merscov
titer
lung
infect
mice
homogen
ml
pb
qualiti
biolog
inc
use
glass
bead
milliporesigma
beadruptor
omni
intern
inc
merscov
titer
pfu
per
millilit
determin
plaqu
assay
vero
cell
convert
pfu
per
gram
lung
base
mass
harvest
lung
tissu
merscov
genom
rna
mrna
quantif
perform
previous
describ
briefli
lung
tissu
harvest
homogen
trizol
ambion
rna
extract
per
manufactur
instruct
use
directzol
rna
miniprep
kit
zymo
research
fast
pcr
mix
life
technolog
use
along
primer
probe
set
target
upe
viral
genom
rna
leader
sequenc
viral
mrna
mous
tfrc
use
endogen
control
rel
express
level
genom
merscov
viral
rna
mrna
determin
tfrc
ct
gene
ct
infect
tfrc
ct
gene
ct
pb
mean
rel
express
valu
uninfect
gene
express
lung
tissu
homogen
ml
trizol
ambion
use
glass
bead
milliporesigma
beadruptor
omni
intern
inc
rna
extract
use
directzol
mini
rna
extract
kit
zymo
research
per
manufactur
instruct
rna
transcrib
cdna
use
high
capac
cdna
revers
transcript
kit
appli
biosystem
gene
express
perform
use
input
cdna
use
powerup
sybr
green
master
mix
flow
cytometri
uninfect
merscovinfect
mice
euthan
isofluran
mice
perfus
use
ml
cold
pb
lung
excis
place
cold
pb
singl
cell
isol
lung
use
gentlemac
system
miltenyi
biotec
lung
place
c
tube
miltenyi
biotec
contain
rpmi
medium
vv
fb
mgml
collagenas
roch
mgml
dnase
roch
lung
run
allow
digest
minut
intermitt
shake
follow
run
cell
suspens
filter
filter
bd
cell
pellet
centrifug
red
blood
cell
lyse
ammoniumchloridepotassium
lysi
buffer
qualiti
biolog
inc
subsequ
wash
rpmi
contain
wv
fb
total
live
cell
count
use
trypan
blue
exclus
approxim
cell
plate
wash
twice
pb
contain
mm
edta
cell
stain
viabil
use
livedead
fixabl
aqua
dead
cell
stain
kit
molecular
probe
cell
wash
pb
contain
mm
edta
resuspend
block
buffer
consist
mous
fc
block
bd
pb
contain
bsa
mm
edta
block
cell
stain
antibodi
cocktail
made
pb
contain
bsa
mm
edta
antibodi
use
follow
alexa
fluor
biolegend
clone
biolegend
clone
bd
clone
ebiosci
clone
ebiosci
clone
fitc
biolegend
clone
apc
biolegend
clone
pe
bd
clone
bd
clone
stain
cell
wash
twice
fix
hour
fluorofix
biolegend
fix
cell
wash
pb
contain
bsa
resuspend
pb
contain
bsa
mm
edta
sampl
acquir
approxim
event
use
lsr
ii
flow
cytomet
beckton
dickinson
data
analyz
use
flowjo
analysi
softwar
flowjo
llc
histolog
formalinfix
lung
embed
paraffin
section
cut
follow
stain
hematoxylin
eosin
patholog
electron
microscopi
histolog
laboratori
univers
maryland
school
medicin
slide
blind
score
boardcertifi
veterinari
pathologist
presenc
patholog
characterist
diseas
includ
perivascular
inflamm
bronchiolar
inflamm
eosinophil
neutrophil
lymphocyt
macrophag
edema
hemorrhag
pleuriti
necrosi
score
scale
use
follow
inflamm
scant
inflamm
multifoc
small
focu
mild
inflamm
parenchyma
moder
inflamm
parenchyma
mark
inflamm
parenchyma
sever
inflamm
parenchyma
statist
statist
analysi
perform
graphpad
prism
metabol
paramet
hfdfed
hm
mice
analyz
use
anova
tukey
posttest
anova
posttest
use
analyz
ipgtt
time
cours
well
weight
loss
clinic
sign
diseas
viru
titer
infiltr
immun
cell
cytokin
chemokin
express
infect
unpair
test
correct
multipl
comparison
use
analyz
viral
genom
rna
mrna
level
variou
tissu
day
infect
statist
analys
done
nonlogtransform
data
statist
signific
defin
p
studi
approv
mous
experi
perform
univers
maryland
school
medicin
accord
protocol
approv
institut
anim
care
use
committe
protocol
us
anim
welfar
act
kak
cmc
mbf
design
experi
kak
cmc
perform
experi
seb
score
lung
patholog
kak
mbf
obtain
fund
wrote
manuscript
